The Interplay between Mitophagy and Ferroptosis in Alzheimer's Disease: Mechanisms and Therapeutic Implications
Abstract
Alzheimer's disease (AD) ischaracterizedby the deposition of amyloid-β (Aβ) and T au neurofibrillary tangles. In recent years, mitophagy, the selective clearance of damaged mitochondria, and ferroptosis, an iron-dependent form of programmed cell death,have emerged as pivotal driversof neurodegeneration in AD. This review systematicallyoutlinesthe molecular mechanisms of mitophagy and ferroptosis,focusing ontheir intricate interplay in AD. Wehypothesizethat impaired mitophagy in AD disrupts intracellular redox and iron homeostasis, thereby increasing neuronal susceptibility to ferroptosis. Conversely, ferroptosis-associated events, such as lipid peroxidation, can further exacerbate mitochondrial dysfunction,thereby establishing a vicious cycle that accelerates disease progression. Furthermore, we summarize potential therapeutic strategies targeting this interactive network (e.g.,Urolithin A, ferroptosis inhibitors) anddiscusspromising future research directions. A deeper understanding of the crosstalk between mitophagy and ferroptosis is therefore crucial for developing novel therapeutic interventions for AD.